BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7680090)

  • 1. Structure/function relationships of muscarinic acetylcholine receptors.
    Brann MR; Klimkowski VJ; Ellis J
    Life Sci; 1993; 52(5-6):405-12. PubMed ID: 7680090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors.
    Voigtländer U; Jöhren K; Mohr M; Raasch A; Tränkle C; Buller S; Ellis J; Höltje HD; Mohr K
    Mol Pharmacol; 2003 Jul; 64(1):21-31. PubMed ID: 12815157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic acetylcholine receptor subtypes: localization and structure/function.
    Brann MR; Ellis J; Jørgensen H; Hill-Eubanks D; Jones SV
    Prog Brain Res; 1993; 98():121-7. PubMed ID: 8248499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscarinic acetylcholine receptors: structural basis of ligand binding and G protein coupling.
    Wess J; Blin N; Mutschler E; Blüml K
    Life Sci; 1995; 56(11-12):915-22. PubMed ID: 10188793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis of receptor/G protein coupling selectivity studied with muscarinic receptors as model systems.
    Wess J; Liu J; Blin N; Yun J; Lerche C; Kostenis E
    Life Sci; 1997; 60(13-14):1007-14. PubMed ID: 9121341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and activation of muscarinic acetylcholine receptors.
    Hulme EC; Lu ZL; Saldanha JW; Bee MS
    Biochem Soc Trans; 2003 Feb; 31(Pt 1):29-34. PubMed ID: 12546648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intramolecular interactions in muscarinic acetylcholine receptors studied with chimeric m2/m5 receptors.
    Pittel Z; Wess J
    Mol Pharmacol; 1994 Jan; 45(1):61-4. PubMed ID: 8302281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allosteric site on muscarinic acetylcholine receptors: a single amino acid in transmembrane region 7 is critical to the subtype selectivities of caracurine V derivatives and alkane-bisammonium ligands.
    Buller S; Zlotos DP; Mohr K; Ellis J
    Mol Pharmacol; 2002 Jan; 61(1):160-8. PubMed ID: 11752217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors.
    Trumpp-Kallmeyer S; Hoflack J; Bruinvels A; Hibert M
    J Med Chem; 1992 Sep; 35(19):3448-62. PubMed ID: 1328638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an in situ disulfide cross-linking strategy to map proximities between amino acid residues in transmembrane domains I and VII of the M3 muscarinic acetylcholine receptor.
    Hamdan FF; Ward SD; Siddiqui NA; Bloodworth LM; Wess J
    Biochemistry; 2002 Jun; 41(24):7647-58. PubMed ID: 12056896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors.
    Jakubík J; Randáková A; Zimčík P; El-Fakahany EE; Doležal V
    Sci Rep; 2017 Jan; 7():40381. PubMed ID: 28091608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of two highly conserved tyrosine residues in the m1 muscarinic receptor second transmembrane domain in ligand binding and receptor function.
    Lee SY; Zhu SZ; el-Fakahany EE
    Recept Signal Transduct; 1996; 6(1):43-52. PubMed ID: 8933621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular modeling of the interaction of diagnostic radiopharmaceuticals with receptor proteins: m2 antagonist binding to the muscarinic m2 subtype receptor.
    Kapp OH; Siemion J; Eckelman WC; Cohen VI; Reba RC
    Recept Signal Transduct; 1997; 7(3):177-201. PubMed ID: 9440504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational disruption of a conserved disulfide bond in muscarinic acetylcholine receptors attenuates positive homotropic cooperativity between multiple allosteric sites and has subtype-dependent effects on the affinities of muscarinic allosteric ligands.
    Huang XP; Ellis J
    Mol Pharmacol; 2007 Mar; 71(3):759-68. PubMed ID: 17132687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple allosteric sites on muscarinic receptors.
    Birdsall NJ; Lazareno S; Popham A; Saldanha J
    Life Sci; 2001 Apr; 68(22-23):2517-24. PubMed ID: 11392621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-directed mutagenesis on the m2 muscarinic acetylcholine receptor: the significance of Tyr403 in the binding of agonists and functional coupling.
    Vogel WK; Sheehan DM; Schimerlik MI
    Mol Pharmacol; 1997 Dec; 52(6):1087-94. PubMed ID: 9415719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutively active muscarinic receptors.
    Spalding TA; Burstein ES
    Life Sci; 2001 Apr; 68(22-23):2511-6. PubMed ID: 11392620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure/function relationships of a G-protein coupling pocket formed by the third intracellular loop of the m5 muscarinic receptor.
    Burstein ES; Spalding TA; Brann MR
    Biochemistry; 1998 Mar; 37(12):4052-8. PubMed ID: 9521726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis of the subtype selectivity of muscarinic antagonists: a study with chimeric m2/m5 muscarinic receptors.
    Wess J; Gdula D; Brann MR
    Mol Pharmacol; 1992 Feb; 41(2):369-74. PubMed ID: 1538713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Site-directed mutagenesis reveals two epitopes involved in the subtype selectivity of the allosteric interactions of gallamine at muscarinic acetylcholine receptors.
    Gnagey AL; Seidenberg M; Ellis J
    Mol Pharmacol; 1999 Dec; 56(6):1245-53. PubMed ID: 10570052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.